GlassScriptPhysician profile
Prabhdeep S Sandhu
NPI 1679568901
$22,330.49
in general payments reported to CMS, 2019-2025
28 companies · $1,863 in 2025
The $1,863 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,811 · 2020: $465 · 2021: $1,290 · 2022: $9,949 · 2023: $3,357 · 2024: $3,597 · 2025: $1,863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,851 · Travel and Lodging: $1,965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,850.99 |
| Travel and Lodging | $1,965.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14,965.52 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $2,335.44 | 2019-2025 | Farapulse, Emblem Mri S-Icd, Emerge Push |
| Edwards Lifesciences Corporation | $1,454.85 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $696.37 | 2020-2025 | Impella |
| Abbott Laboratories | $680.16 | 2020-2025 | Navitor, Coroflow, Pressurewire |
| Medtronic Vascular, INC. | $534.47 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $453.03 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $276.48 | 2022-2025 | Camzyos, Eliquis |
| Penumbra, INC. | $147.52 | 2023 | Indigo System |
| Astrazeneca Pharmaceuticals LP | $122.64 | 2019-2025 | Farxiga |
| Pfizer INC. | $83.24 | 2019-2025 | |
| Shockwave Medical, INC | $57.97 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $55.84 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.61 | 2019-2021 | |
| Braemar Manufacturing, LLC | $55.52 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $52.48 | 2019-2021 | |
| Heartflow, INC. | $40.87 | 2025 | |
| Acist Medical Systems, INC. | $36.42 | 2019 | |
| Amgen INC. | $33.51 | 2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.10 | 2024 | Jardiance |
| Alnylam Pharmaceuticals INC. | $23.04 | 2024 | Amvuttra |
| Cardiva Medical, INC. | $22.94 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Lexicon Pharmaceuticals, INC. | $22.65 | 2024 | |
| Cardiovascular Systems INC. | $22.50 | 2019 | |
| Irhythm Technologies, INC. | $21.08 | 2024 | Zio Xt Patch, Zio Monitor |
| Sanofi-Aventis U.S. LLC | $20.53 | 2019 | |
| Vertiflex, INC. | $19.36 | 2019 | |
| Biomerieux INC | $10.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabhdeep Sandhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.